Kageyama, S <br/><br/>
In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  May 1992 
 - 926-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.36.5.926  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Didanosine--pharmacology<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>HIV Protease Inhibitors<br/>HIV-1--drug effects<br/>Humans<br/>Virus Replication--drug effects<br/>Zidovudine--pharmacology